This is “extremely important” for the pharmaceutical industry to track, and other companies may try to follow in Allergan’s footsteps, a Wall Street analyst said.
<
This is “extremely important” for the pharmaceutical industry to track, and other companies may try to follow in Allergan’s footsteps, a Wall Street analyst said.
<